Optimal vaccine schedules to maintain measles elimination with a two-dose routine policy

Epidemiol Infect. 2017 Jan;145(2):227-235. doi: 10.1017/S0950268816002296. Epub 2016 Oct 20.

Abstract

Measles was eliminated in the Americas in 2002 by a combination of routine immunizations and supplementary immunization activities. Recent outbreaks underscore the importance of reconsidering vaccine policy in order to maintain elimination. We constructed an age-structured dynamical model for the distribution of immunity in a population with routine immunization and without disease, and analysed the steady state for an idealized age structure and for real age structures of countries in the Americas. We compared the level of immunity maintained by current policy in these countries to the level maintainable by an optimal policy. The optimal age target for the first routine dose of measles vaccine depends on the timing and coverage of both doses. Similarly, the optimal age target for the second dose of measles vaccine depends on the timing and coverage of the first dose. The age targets for the first and second doses of measles vaccine should be adjusted for the post-elimination era, by specifically accounting for current context, including realized coverage of both doses, and altered maternal immunity. Doing so can greatly improve the proportion immune within a population, and therefore the chances of maintaining measles elimination, without changing coverage.

Keywords: Maintenance of measles elimination; mathematical modelling; measles (rubeola); vaccination (immunization); vaccine policy development.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Americas / epidemiology
  • Child
  • Child, Preschool
  • Disease Eradication*
  • Female
  • Health Policy
  • Humans
  • Immunization Schedule*
  • Infant
  • Infant, Newborn
  • Male
  • Measles / prevention & control*
  • Measles Vaccine / administration & dosage*
  • Middle Aged
  • Models, Statistical
  • Young Adult

Substances

  • Measles Vaccine